ITGAE and atherosclerosis: Intravenous administration of oxLDL-induced apoptotic DCs to LDLR−/− mice reduces atherosclerosis and increases plaque stability by increasing CD103+ tolerogenic DC and Treg numbers and reducing the numbers of Ly6Chi monocytes and the level of circulating CCL12 [324].